Robin Kramer Biogen Inc. (BIIB) insider trading activity

Robin Kramer is Chief Accounting Officer of BIOGEN INC.. Currently has a direct ownership of 8,011 shares of BIIB, which is worth approximately $1.1 Million. The most recent transaction as insider was on Feb 18, 2022, when has been sold 117 shares (Common Stock) at a price of $209.79 per share, resulting in proceeds of $24,545. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.01K

25.04% 3M change

28.67% 12M change

Total Value Held $1.1 Million

Robin Kramer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2022	SELL Payment of exercise price or tax liability	$24,545 $209.79 p/Share	117 Reduced 6.31%	1,737 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	-	396 Added 17.6%	1,854 Common Stock
Feb 12 2022	SELL Payment of exercise price or tax liability	$36,695 $214.59 p/Share	171 Reduced 10.5%	1,458 Common Stock
Feb 12 2022	BUY Exercise of conversion of derivative security	-	275 Added 14.71%	1,594 Common Stock
Jan 19 2022	BUY Grant, award, or other acquisition	-	244 Added 15.27%	1,354 Common Stock
Dec 03 2021	SELL Payment of exercise price or tax liability	$22,392 $223.92 p/Share	100 Reduced 8.26%	1,110 Common Stock
Dec 03 2021	BUY Exercise of conversion of derivative security	$75,909 $223.92 p/Share	339 Added 21.89%	1,210 Common Stock
Jul 01 2021	SELL Payment of exercise price or tax liability	$25,820 $348.92 p/Share	74 Reduced 7.83%	871 Common Stock
Jul 01 2021	BUY Exercise of conversion of derivative security	$87,579 $348.92 p/Share	251 Added 20.99%	945 Common Stock
Feb 12 2021	SELL Payment of exercise price or tax liability	$31,973 $278.03 p/Share	115 Reduced 16.29%	591 Common Stock
Feb 12 2021	BUY Exercise of conversion of derivative security	-	333 Added 32.05%	706 Common Stock
Dec 03 2020	SELL Payment of exercise price or tax liability	$5,370 $244.09 p/Share	22 Reduced 5.57%	373 Common Stock
Dec 03 2020	BUY Exercise of conversion of derivative security	-	74 Added 15.78%	395 Common Stock

Also insider at

ARMP

Armata Pharmaceuticals, Inc. Healthcare

Director

Robin Kramer

Chief Accounting Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIIB shares.

Notify only if

Value

Insider Trading

Get notified when an Biogen Inc. insider buys or sells BIIB shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOGEN INC.

Track Activities on BIIB

Account